Literature DB >> 9128982

alpha-2,3-Sialyltransferase type 3N and alpha-1,3-fucosyltransferase type VII are related to sialyl Lewis(x) synthesis and patient survival from lung carcinoma.

J I Ogawa1, H Inoue, S Koide.   

Abstract

BACKGROUND: Biosynthesis of sialyl Lewis(x) (sLe(x)) requires a sialyltransferase for alpha-2,3-sialylation and a fucosyltransferase for alpha-1,3-fucosylation. To date, five human alpha-1,3-fucosyltransferase (Fuc-T) genes and five human alpha-2,3-sialyltransferase (ST) genes have been cloned. However, it is not known which enzyme is mainly responsible for sLe(x) synthesis.
METHODS: Three hundred thirteen patients with nonsmall cell lung carcinoma who had a curative tumor resection were the subjects of this study. Using tumor tissues fixed in formaldehyde, amplification of genomic DNA of Fuc-T and ST was performed by PCR and correlated with sLe(x) staining and patient prognosis.
RESULTS: The frequency of strong ST3N and Fuc-TVII amplification was significantly higher than that of STZ, ST4, Fuc-TIII, Fuc-TV, and Fuc-TVI amplification (P < 0.01). The frequency of sLe(x) staining was similar to ST3N and Fuc-TVII amplification. Survival of the patients whose tumors had strong amplification of both ST3N and Fuc-TVII was significantly shorter than that of patients whose tumors had no amplification of either gene (P < 0.01). In a multivariate analysis of survival, Fuc-TVII remained a statistically significant prognostic factor.
CONCLUSIONS: In lung carcinoma, ST3N and Fuc-TVII may both be related to sLe(x) synthesis, and Fuc-TVII is a more important indicator of poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128982     DOI: 10.1002/(sici)1097-0142(19970501)79:9<1678::aid-cncr7>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

Review 2.  Glycosylation: a hallmark of cancer?

Authors:  Bhairavi N Vajaria; Prabhudas S Patel
Journal:  Glycoconj J       Date:  2016-12-14       Impact factor: 2.916

3.  Neutrophil interactions with sialyl Lewis X on human nonsmall cell lung carcinoma cells regulate invasive behavior.

Authors:  Catherine A St Hill; Katherine Krieser; Mariya Farooqui
Journal:  Cancer       Date:  2011-03-22       Impact factor: 6.860

4.  Systems-level studies of glycosyltransferase gene expression and enzyme activity that are associated with the selectin binding function of human leukocytes.

Authors:  Dhananjay D Marathe; E V Chandrasekaran; Joseph T Y Lau; Khushi L Matta; Sriram Neelamegham
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

5.  Aberrant glycosylation associated with enzymes as cancer biomarkers.

Authors:  Danni L Meany; Daniel W Chan
Journal:  Clin Proteomics       Date:  2011-06-03       Impact factor: 3.988

6.  Regulation of differentiation- and proliferation-inducers on Lewis antigens, alpha-fucosyltransferase and metastatic potential in hepatocarcinoma cells.

Authors:  F Liu; H L Qi; H L Chen
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

7.  Overexpression of alpha(1,3)-fucosyltransferase VII is sufficient for the acquisition of lung colonization phenotype in human lung adenocarcinoma HAL-24Luc cells.

Authors:  M Martín-Satué; C de Castellarnau; J Blanco
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

8.  Intensity of SLX predicts distance of tumor spread through alveolar spaces in stage I lung adenocarcinoma.

Authors:  Kantaro Hara; Shinjiro Mizuguchi; Satoshi Okada; Nobuhiro Izumi; Takuma Tsukioka; Hiroaki Komatsu; Masahiko Ohsawa; Mayumi Inaba; Toshihiko Shibata; Noritoshi Nishiyama
Journal:  Thorac Cancer       Date:  2019-02-28       Impact factor: 3.500

Review 9.  The sweet and sour of serological glycoprotein tumor biomarker quantification.

Authors:  Uros Kuzmanov; Hari Kosanam; Eleftherios P Diamandis
Journal:  BMC Med       Date:  2013-02-07       Impact factor: 8.775

10.  α-1,3-Fucosyltransferase-VII siRNA inhibits the expression of SLex and hepatocarcinoma cell proliferation.

Authors:  Dongsheng Li; Hongzhi Sun; Guang Bai; Wei Wang; Miaomiao Liu; Zhiye Bao; Jingjing Li; Hao Liu
Journal:  Int J Mol Med       Date:  2018-08-31       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.